
The global gastrointestinal bleeding treatment market is set to expand moderately at a CAGR of 5.1% between 2020 and 2026, attributed to preference for endoscopic hemostasis to correct GI problems. Gastrointestinal problems, particularly upper gastrointestinal bleeding (UGIB), are becoming more prevalent across the world. It
source
https://www.openpr.com/news/2241110/gastrointestinal-bleeding-treatment-market-projected